IO Month - session 3 - 952x200

Resistance to immunotherapies: Turning cold into hot - firing up the TME

Watch on demand our second session of 'New Directions in Immuno-oncology: Response and Resistance' held on February 10, 2021

​​Webinar objectives

  • Discover how hypoxia drives tumor immune suppression and immunotherapy resistance
  • Discuss overcoming resistance to STING-induced anti-tumour immunity
  • Utilize in vivo labelling system to identify and isolate cells from the metastatic niche

​Abcam is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program.  Interested in receiving P.A.C.E credit for this educational session? Request credit here!


Speakers

  • Michael Curran, MD Anderson Cancer Center, USA​
    • Hypoxia drives tumor immune suppression and immunotherapy resistance
    • Timestamp: 2:35 - 37:02
  • Andrew Mellor, Newcastle University, UK​
    • ​Overcoming resistance to STING-induced anti-tumour immunity
    • Timestamp: 38:06 - 1:06:45
  • Luigi Ombrato, Barts Cancer Institute - Queen Mary University of London, UK
    • ​Tumour microenvironment de-construction: a tool to study inter-cellular interactions in the niche
    • Timestamp: 1:07:40 - 1:32:30

Contact
​Have a question? Please contact the Abcam Events Team.